Adipose AMPKα2 activation leads to inhibition of fatty acid synthase and consequently, of lipogenesis, resulting in body weight reduction, but it also impairs insulin signaling which, in combination with the elevated levels of circulating free fatty acids, contribute to the development of tissue insulin resistance [10,11]. This evidence concerns the gene PRKAA2 and Insulin resistance.